Skip to content
AnalystLens

PROCTER & GAMBLE Co 8-K Report (Jul 11, 1997)

Reports
Other Events
Filing Date
Filed July 11, 1997
Period End
July 11, 1997
Security
PG
In the record · 2016–202610-K1210-Q328-K226

PG filed 12 annual reports (10-K), 32 quarterly reports (10-Q) and 226 current reports (8-K) between 2016 and 2026.

  1. FY2019 annual report10-K · Aug ’19Aug ’19
  2. Leadership change8-K · Jan ’22Jan ’22
  3. Leadership change8-K · Dec ’25Dec ’25

Summary

Summary of the 8-K filed July 11, 1997. Cited figures are marked; the original filing is the authoritative source.

The Procter & Gamble Company filed this Form 8-K on July 11, 1997, under Item 9 (Sales of Equity Securities Pursuant to Regulations).

The filing is a routine disclosure of a small private placement rather than a material corporate event. On June 25, 1997, P&G sold 3,564 shares of its common stock to employees of its subsidiaries for approximately $490,831,a relying on Regulation S, which exempts offshore offerings from U.S. registration requirements. The transaction is immaterial to P&G's financial position.

At roughly $138b per share implied by the figures, the proceeds are a negligible fraction of a company of P&G's size, and the filing contains no information about earnings, guidance, strategy, acquisitions, dividends, or litigation. The sale was made without an underwriter or placement agent, which indicates a direct employee-related issuance rather than a market offering. For investors, the primary takeaway is that this filing carries no meaningful investment signal.

It should be read as a compliance disclosure that the company is required to make when it issues securities under Regulation S. Investors seeking to evaluate P&G should focus on the company's annual report (Form 10-K) and quarterly reports (Form 10-Q), which contain its financial results and operating outlook.

Key Highlights

  1. Filing type: Form 8-K, Item 9, reporting an unregistered sale of equity securities.
  2. Transaction date: June 25, 1997, with the 8-K filed July 11, 1997.
  3. Shares issued: 3,564 shares of P&G common stock.
  4. Proceeds: approximately $490,831, implying roughly $138 per share.
  5. Buyers: employees of P&G subsidiaries, not the public market.
  6. Exemption relied upon: Regulation S (offshore offerings), with no underwriter or placement agent used.
  7. Financial materiality: negligible relative to P&G's overall capitalization and operations; no operational, earnings, or strategic information disclosed.

Frequently Asked Questions

  1. Does this 8-K filing signal anything about P&G's financial health?

    No. The filing reports a small employee share sale totaling about $490,831. It contains no financial results, guidance, or forward-looking statements, so it provides no meaningful evidence about P&G's financial health or performance.

  2. Why did P&G sell shares to employees of its subsidiaries?

    The filing does not state a purpose. Such sales are typically tied to employee stock purchase or compensation arrangements, but the 8-K does not confirm the specific program or reason.

  3. What is Regulation S, and why does it matter here?

    Regulation S is an SEC safe harbor that exempts certain offers and sales made outside the United States from the registration requirements of the Securities Act of 1933. Because the sale relied on it, P&G did not register these shares with the SEC, which is consistent with a limited offering to non-U.S. employees.

  4. Would this transaction dilute existing P&G shareholders?

    Only negligibly. The 3,564 shares are a very small fraction of P&G's total outstanding common stock, so any dilution effect is immaterial.

  5. Where should investors look for information on P&G's performance in 1997?

    Investors should review P&G's Form 10-K annual report and Form 10-Q quarterly reports filed with the SEC, along with the company's earnings releases and investor presentations, which cover results, segment performance, and outlook.